Actively Recruiting
Stereotactic Multiple Fraction Radiotherapy for Non-spine Bone Metastases
Led by Kantonsspital Winterthur KSW · Updated on 2025-05-22
162
Participants Needed
2
Research Sites
208 weeks
Total Duration
On this page
Sponsors
K
Kantonsspital Winterthur KSW
Lead Sponsor
K
Krebsforschung Schweiz, Bern, Switzerland
Collaborating Sponsor
AI-Summary
What this Trial Is About
To investigate, whether multi-fraction stereotactic body radiation therapy (SBRT) within 3 treatment fractions is non-inferior to the current standard of care of 5 fraction SBRT regarding pain response at 3 months after radiotherapy.
CONDITIONS
Official Title
Stereotactic Multiple Fraction Radiotherapy for Non-spine Bone Metastases
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Personally signed and dated written informed consent
- Histological diagnosis of malignancy
- Histologically or radiologically diagnosed bone metastasis
- Age 63 18 years
- Pain or under pain control medication
You will not qualify if you...
- Pregnant or lactating women
- Women of childbearing potential or sexually active males not willing to use effective contraception while on treatment and 3 months after the end of treatment
- Inability to follow the procedures of the study, e.g., due to language problems, psychological disorders, dementia, etc.
- Prior radiotherapy to the intended treatment site
- Lesions > 5cm in maximum diameter
- Prior treatment with radioactive isotopes within 30 days of randomisation
- Spinal column, hands, feet, or head as intended treatment site
- Fracture at the intended treatment site
- Surgery required or previous surgery at the intended treatment site
- Instability of the intended treatment site
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Kantonsspital Winterthur
Winterthur, Canton of Zurich, Switzerland, 8401
Actively Recruiting
2
University Hospital Bern
Bern, Switzerland, 3010
Actively Recruiting
Research Team
R
Robert Foerster, MD
CONTACT
N
Nidar Batifi, RN
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here